NanoVibronix Partners With Peak Medical

NanoVibronix Inc. has partnered with Peak Medical Ltd., a continence care patient focused company based in the United Kingdom, to broaden the latter firm’s product distribution capabilities.
 
“We are enthusiastic about partnering with Peak Medical, a company that provides first class products and services for catheter and continence care to NHS hospitals and communities throughout the United Kingdom,” NanoVibronix CEO Brian Murphy said. “Peak Medical has a management team with vast experience in urological medicine leading a team of significant sales and marketing resources with strong distribution capabilities throughout the UK and Ireland.”
 
“We anticipate a strong uptake of UroShield given patient demand for the device in the National Health Service. The UroShield device has been progressed by the NHS National Institute for Health and Care Excellence (NICE) and has recently been approved for sale through a contract with the NHS Supply Chain,” Peak Medical Commercial Director Paul Newman stated. “Our experienced sales team are exclusively focused on catheter and stoma care products and passionately believe patients and clinicians deserve products which allow the best quality of life and ease of use. The UroShield device comes at a pivotal time for long-term catheter patients, living in their own homes, nursing homes, long-term care facilities, or hospitals who are at risk of Catheter Associated Urinary Tract Infections (CAUTIs) and catheter blockage. UroShield enables clinicians to potentially prevent the incidence of infections and catheter blockages in the most vulnerable patients that further complicates their care, extends the duration of hospital stays or increases the risk of readmission when it is critical for our healthcare system to maximize its limited resources.”
 
NanoVibronix Inc. is a medical device company headquartered in Elmsford, N.Y., with R&D in Nesher, Israel, focused on developing medical devices utilizing its patented low intensity surface acoustic wave (SAW) technology. The proprietary technology allows for the creation of low-frequency ultrasound waves that can be utilized for a variety of medical applications, including for disruption of biofilms and bacterial colonization, as well as for pain relief. The devices can be administered at home without the assistance of medical professionals. The Company’s primary products include PainShield, UroShield and WoundShield, all of which are portable devices suitable for administration at home without assistance of medical professionals.